Morgan Stanley’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$107K Sell
342,636
-2,529,588
-88% -$787K ﹤0.01% 6105
2025
Q1
$1.4M Sell
2,872,224
-5,943,556
-67% -$2.91M ﹤0.01% 4821
2024
Q4
$7.55M Sell
8,815,780
-1,088,750
-11% -$932K ﹤0.01% 3632
2024
Q3
$84.2M Buy
9,904,530
+6,384,793
+181% +$54.3M 0.01% 1379
2024
Q2
$16.4M Buy
3,519,737
+325,685
+10% +$1.52M ﹤0.01% 2878
2024
Q1
$21.7M Buy
3,194,052
+3,086,806
+2,878% +$21M ﹤0.01% 2605
2023
Q4
$359K Buy
107,246
+55,875
+109% +$187K ﹤0.01% 5742
2023
Q3
$128K Sell
51,371
-3,353
-6% -$8.35K ﹤0.01% 5766
2023
Q2
$70K Buy
54,724
+54,528
+27,820% +$69.8K ﹤0.01% 6086
2023
Q1
$159 Sell
196
-4,284
-96% -$3.48K ﹤0.01% 7533
2022
Q4
$3.41K Sell
4,480
-15,597
-78% -$11.9K ﹤0.01% 7245
2022
Q3
$18K Sell
20,077
-89,519
-82% -$80.3K ﹤0.01% 6827
2022
Q2
$103K Buy
109,596
+89,170
+437% +$83.8K ﹤0.01% 6258
2022
Q1
$43K Buy
20,426
+1,617
+9% +$3.4K ﹤0.01% 6778
2021
Q4
$168K Buy
18,809
+4,212
+29% +$37.6K ﹤0.01% 6152
2021
Q3
$242K Buy
14,597
+516
+4% +$8.56K ﹤0.01% 5895
2021
Q2
$294K Buy
14,081
+20
+0.1% +$418 ﹤0.01% 5824
2021
Q1
$264K Buy
14,061
+2,483
+21% +$46.6K ﹤0.01% 5495
2020
Q4
$255K Buy
11,578
+5,436
+89% +$120K ﹤0.01% 5467
2020
Q3
$128K Sell
6,142
-56,874
-90% -$1.19M ﹤0.01% 5310
2020
Q2
$2.28M Buy
63,016
+59,386
+1,636% +$2.15M ﹤0.01% 3478
2020
Q1
$119K Sell
3,630
-6,461
-64% -$212K ﹤0.01% 5112
2019
Q4
$275K Buy
10,091
+9,576
+1,859% +$261K ﹤0.01% 5267
2019
Q3
$6K Buy
+515
New +$6K ﹤0.01% 6321